Hamideh Parhiz

4.8k total citations · 6 hit papers
37 papers, 2.7k citations indexed

About

Hamideh Parhiz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hamideh Parhiz has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Genetics and 5 papers in Oncology. Recurrent topics in Hamideh Parhiz's work include RNA Interference and Gene Delivery (21 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Hamideh Parhiz is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Hamideh Parhiz collaborates with scholars based in United States, Iran and Sweden. Hamideh Parhiz's co-authors include Fatemeh Soltani, Ali Roohbakhsh, Ramin Rezaee, Mehrdad Iranshahi, Drew Weissman, Vladimir R. Muzykantov, Mohammad Ramezani, Vladimir V. Shuvaev, Makan Khoshnejad and Elena N. Atochina‐Vasserman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hamideh Parhiz

34 papers receiving 2.6k citations

Hit Papers

Antioxidant and Anti-Infl... 2014 2026 2018 2022 2014 2021 2023 2018 2024 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
    2014 719 citations Hamideh Parhiz, Ali Roohbakhsh et al. profile →
  2. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
    2021 183 citations István Tombácz, Dorottya Laczkó et al. Molecular Therapy profile →
  3. In vivo hematopoietic stem cell modification by mRNA delivery
    2023 176 citations Laura Breda, Tyler E. Papp et al. profile →
  4. PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
    2018 154 citations Hamideh Parhiz, Vladimir V. Shuvaev et al. Journal of Controlled Release profile →
  5. mRNA-based therapeutics: looking beyond COVID-19 vaccines
    2024 112 citations Hamideh Parhiz, Elena N. Atochina‐Vasserman et al. The Lancet profile →
  6. In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
    2023 108 citations Margaret M. Billingsley, Ningqiang Gong et al. Small profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hamideh Parhiz 1.4k 320 273 259 258 37 2.7k
Eun Hee Han 1.6k 1.1× 299 0.9× 134 0.5× 299 1.2× 363 1.4× 128 3.3k
Anna Rita Cappello 1.9k 1.3× 205 0.6× 234 0.9× 327 1.3× 478 1.9× 93 3.6k
Vivek R. Yadav 1.7k 1.2× 250 0.8× 98 0.4× 311 1.2× 381 1.5× 60 3.5k
Shih‐Lan Hsu 1.6k 1.1× 215 0.7× 141 0.5× 435 1.7× 338 1.3× 111 3.7k
Eun Ji Kim 1.9k 1.3× 221 0.7× 139 0.5× 333 1.3× 246 1.0× 193 3.6k
Muhajir Hamid 1.1k 0.7× 362 1.1× 151 0.6× 417 1.6× 154 0.6× 97 2.6k
Haitao Xiao 1.0k 0.7× 139 0.4× 268 1.0× 445 1.7× 247 1.0× 110 2.7k
Dongli Li 1.3k 0.9× 292 0.9× 92 0.3× 554 2.1× 193 0.7× 255 4.0k
Chandrasekharan Guruvayoorappan 1.0k 0.7× 135 0.4× 166 0.6× 265 1.0× 319 1.2× 73 2.2k
Ján Mojžíš 1.4k 1.0× 300 0.9× 138 0.5× 436 1.7× 265 1.0× 139 3.1k

Countries citing papers authored by Hamideh Parhiz

Since Specialization
Citations

This map shows the geographic impact of Hamideh Parhiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamideh Parhiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamideh Parhiz more than expected).

Fields of papers citing papers by Hamideh Parhiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamideh Parhiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamideh Parhiz. The network helps show where Hamideh Parhiz may publish in the future.

Co-authorship network of co-authors of Hamideh Parhiz

This figure shows the co-authorship network connecting the top 25 collaborators of Hamideh Parhiz. A scholar is included among the top collaborators of Hamideh Parhiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamideh Parhiz. Hamideh Parhiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yashaswini, Chittampalli N., Bruno Cogliati, Tyler E. Papp, et al.. (2026). Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis. Science Translational Medicine. 18(833). eadx0368–eadx0368.
3.
Kimura, Kenji, Caitlin M. Tilsed, Karen P. Fong, et al.. (2025). In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo. Vaccines. 13(2). 178–178. 1 indexed citations
4.
Breda, Laura, Tyler E. Papp, Enrico Radaelli, et al.. (2024). An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA. Blood. 145(1). 98–113.
5.
Tilsed, Caitlin M., Tyler E. Papp, Kenji Kimura, et al.. (2024). IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation. Proceedings of the National Academy of Sciences. 121(13). e2319856121–e2319856121. 24 indexed citations
6.
Parhiz, Hamideh, Elena N. Atochina‐Vasserman, & Drew Weissman. (2024). mRNA-based therapeutics: looking beyond COVID-19 vaccines. The Lancet. 403(10432). 1192–1204. 112 indexed citations breakdown →
7.
Mukalel, Alvin J., Alex G. Hamilton, Margaret M. Billingsley, et al.. (2024). Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering. Advanced Functional Materials. 34(27). 26 indexed citations
8.
Parhiz, Hamideh, Vladimir V. Shuvaev, Qin Li, et al.. (2024). Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy — Nucleic Acids. 35(2). 102175–102175. 11 indexed citations
9.
Parhiz, Hamideh, et al.. (2023). Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis. Haematologica. 108(10). 2582–2593. 8 indexed citations
10.
Billingsley, Margaret M., Ningqiang Gong, Alvin J. Mukalel, et al.. (2023). In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism. Small. 20(11). e2304378–e2304378. 108 indexed citations breakdown →
11.
Tombácz, István, Dorottya Laczkó, Hamna Shahnawaz, et al.. (2021). Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs. Molecular Therapy. 29(11). 3293–3304. 183 indexed citations breakdown →
12.
Parhiz, Hamideh, Vladimir V. Shuvaev, Norbert Pardi, et al.. (2018). PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake. Journal of Controlled Release. 291. 106–115. 154 indexed citations breakdown →
13.
Khoshnejad, Makan, Hamideh Parhiz, Vladimir V. Shuvaev, Ivan J. Dmochowski, & Vladimir R. Muzykantov. (2018). Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting. Journal of Controlled Release. 282. 13–24. 114 indexed citations
14.
Khoshnejad, Makan, William W. Motley, Hamideh Parhiz, et al.. (2018). Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9. Scientific Reports. 8(1). 1760–1760. 26 indexed citations
15.
Hashemi, Maryam, et al.. (2015). PEGylation of Polypropylenimine Dendrimer with Alkylcarboxylate Chain Linkage to Improve DNA Delivery and Cytotoxicity. Applied Biochemistry and Biotechnology. 177(1). 1–17. 18 indexed citations
16.
Roohbakhsh, Ali, Hamideh Parhiz, Fatemeh Soltani, Ramin Rezaee, & Mehrdad Iranshahi. (2015). Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sciences. 124. 64–74. 308 indexed citations
17.
Hashemi, Maryam, et al.. (2015). Preparation of Effective and Safe Gene Carriers by Grafting Alkyl Chains to Generation 5 Polypropyleneimine. AAPS PharmSciTech. 16(5). 1002–1012. 11 indexed citations
18.
Parhiz, Hamideh, et al.. (2014). In vitro protective effects of Scutellaria litwinowii root extract against H 2 O 2 -induced DNA damage and cytotoxicity. Journal of Complementary and Integrative Medicine. 11(2). 121–127. 5 indexed citations
19.
Roohbakhsh, Ali, Hamideh Parhiz, Fatemeh Soltani, Ramin Rezaee, & Mehrdad Iranshahi. (2014). Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin — A mini-review. Life Sciences. 113(1-2). 1–6. 163 indexed citations
20.
Hashemi, Maryam, et al.. (2013). Gene Transfer Enhancement by Alkylcarboxylation of Poly(propylenimine). SHILAP Revista de lepidopterología. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun Hee Han Breakdown of academic impact, for papers by Anna Rita Cappello Breakdown of academic impact, for papers by Vivek R. Yadav Breakdown of academic impact, for papers by Shih‐Lan Hsu Breakdown of academic impact, for papers by Eun Ji Kim Breakdown of academic impact, for papers by Muhajir Hamid Breakdown of academic impact, for papers by Haitao Xiao Breakdown of academic impact, for papers by Dongli Li Breakdown of academic impact, for papers by Chandrasekharan Guruvayoorappan Breakdown of academic impact, for papers by Ján Mojžíš
Rankless by CCL
2026